Related Experiment Videos
Liposomes in vivo; conversion of liposomal cholesterol to bile salts
G L Scherphof1, F Kuipers, J T Derksen
1Laboratory of Physiological Chemistry, University of Groningen, The Netherlands.
Biochemical Society Transactions
|December 1, 1987
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Role of bile acid receptor FXR in development and function of brown adipose tissue.
Biochimica et biophysica acta. Molecular and cell biology of lipids·2022
Gut-microbe derived TMAO and its association with more progressed forms of AF: Results from the AF-RISK study.
International journal of cardiology. Heart & vasculature·2021
Anabolic competence: Assessment and integration of the multimodality interventional approach in disease-related malnutrition.
Nutrition (Burbank, Los Angeles County, Calif.)·2019
TUB gene expression in hypothalamus and adipose tissue and its association with obesity in humans.
International journal of obesity (2005)·2017
Nuclear envelope rupture and resealing: mechanisms, consequences, and disease implications.
Biochemical Society transactions·2026
Unmasking programmed cell death in rhinovirus-driven asthma pathology.
Biochemical Society transactions·2026
Exploring the antifungal activity of the wheat microbiome.
Biochemical Society transactions·2026
The role of IRF5 as an immune regulator.
Biochemical Society transactions·2026
Overview of pathways and dynamic interactions of c-type cytochromes in Geobacter sulfurreducens.
Biochemical Society transactions·2026
Building peroxisomes: perspectives on plant peroxins.
Biochemical Society transactions·2026
Proteolytic remodeling by Yme1 enables mitochondrial-derived compartment formation.
bioRxiv : the preprint server for biology·2026
Oxidative Stress as a Pathophysiological Core of Obesity: Preclinical Evidence for Antioxidant-Based Therapy Strategies.
Pharmaceuticals (Basel, Switzerland)·2026
Flavonoids for MASLD: Hepatic Lipid Targets, Biopharmaceutic Barriers, and Formulation Strategies.
Pharmaceuticals (Basel, Switzerland)·2026